Prone Positioning and Abdominal Binding on Lung and Muscle Protection in ARDS Patients During Spontaneous Breathing
Launched by UNIVERSITY OF CHILE · Apr 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different positioning and support methods can help protect the lungs and muscles of patients with Acute Respiratory Distress Syndrome (ARDS) who are transitioning from mechanical ventilation to spontaneous breathing. Specifically, the researchers want to see if lying face down (prone positioning) or using a special binding around the abdomen while lying on the back can reduce injuries to the lungs and muscles that often occur during this transition. This is important because complications from long-term mechanical ventilation can make it harder for patients to recover and can lead to more serious health issues.
To be eligible for the study, participants must be adults with moderate to severe ARDS who have been on a mechanical ventilator for more than three days and have stable vital signs. They should also be alert enough to start breathing on their own. Participants in the trial will undergo assessments to understand their muscle and lung function better and will be placed in different positions to see which method helps them breathe more easily and safely. This study aims to find better ways to support patients during a critical time in their recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult ARDS patients with moderate-severe ARDS on controlled protective mechanical ventilation for more than 3 days
- • Stable hemodynamics
- • Level of consciousness enough to initiate spontaneous breathing
- Exclusion Criteria:
- • Unstable hemodynamics
- • Tracheostomy
- • Abnormal level of consciousness
- • Central nervous system injury
- • Esophageal varices
- • Pregnancy
- • Contraindications for installation of electrical impedance tomography or ultrasound assessments
About University Of Chile
The University of Chile, a leading academic institution in South America, is dedicated to advancing medical research and improving public health through innovative clinical trials. With a strong emphasis on collaboration among multidisciplinary teams, the university leverages its extensive resources and expertise to conduct rigorous and ethically sound studies. By integrating cutting-edge scientific methodologies and fostering partnerships with healthcare providers, the University of Chile aims to contribute valuable insights to the medical community and enhance patient care both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Independencia, , Chile
Patients applied
Trial Officials
Rodrigo Cornejo
Principal Investigator
University of Chile
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported